Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience

S J Singh1, G D H Croaker, P Manglick

  • 1Consultant Paediatric Surgeon, Department of Paediatric Surgery, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK. Shailinder@aol.com

Insights

Hirschsprung

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Genetics

Background:

  • Hirschsprung's disease (HD) is a congenital condition affecting the large intestine, causing functional obstruction.
  • Accurate data on HD demographics, incidence, and treatment in Australia were previously limited.
  • The Australian Paediatric Surveillance Unit (APSU) initiated a system to gather comprehensive HD data.

Purpose of the Study:

  • To collect and analyze data on the demographics, incidence, and clinical features of Hirschsprung's disease in Australian children.
  • To investigate associated anomalies, diagnostic methods, and surgical treatments for HD.
  • To evaluate the incidence and management of enterocolitis in HD patients.

Main Methods:

  • A nationwide prospective study using the APSU system from January 1997 to December 2000.
  • Inclusion criteria: Children under 15 years with biopsy-confirmed Hirschsprung's disease.
  • Data collected on demographics, family history, associated anomalies, clinical presentation, investigations, and surgical procedures.

Main Results:

  • 127 cases of HD reported; 126 with near-complete data.
  • 90% of cases presented neonatally, with 57% experiencing delayed meconium passage.
  • The Soave procedure (65%) was the most common surgery; primary pull-through (51%) is increasingly utilized. Enterocolitis remains a significant concern (12% pre-operative, 21% post-operative).

Conclusions:

  • Hirschsprung's disease is predominantly diagnosed in neonates in Australia.
  • The Soave procedure is the preferred surgical approach, with a rising trend in primary pull-through operations.
  • Enterocolitis continues to be a significant complication requiring careful management in HD patients.